Immune drug doesn't help kids with hard-to-treat kidney disorder EurekAlert (press release) Unfortunately, rituximab does not appear to benefit children who have INS that is resistant to standard treatments, according to a study appearing in an upcoming issue of new study in the Journal of the American Society of Nephrology (JASN). and more »

...